Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
304 GBX | +4.83% | +10.14% | +7.42% |
26/04 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
26/04 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Business Summary
Number of employees: 1,988
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oncology/Immunology - Research and Development
43.5
%
| 307 | 9.2 % | 2,853 | 43.5 % | +829.49% |
Other Ventures
36.9
%
| 2,056 | 61.6 % | 2,422 | 36.9 % | +17.81% |
Oncology/Immunology - Marketed Products
19.6
%
| 976 | 29.2 % | 1,285 | 19.6 % | +31.68% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
57.9
%
| 3,339 | 100.0 % | 3,796 | 57.9 % | +13.69% |
United States and Others
42.1
%
| 0 | 0.0 % | 2,764 | 42.1 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 01/05/01 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 01/08/01 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/22/01 |
Karen Atkin
COO | Chief Operating Officer | 58 | 01/21/01 |
Edith Shih
BRD | Director/Board Member | 71 | 01/00/01 |
Mark Lee
IRO | Public Communications Contact | 46 | - |
Selina Zhang
HRO | Human Resources Officer | - | 01/22/01 |
Yiling Cui
LAW | General Counsel | - | - |
Charles Nixon
LAW | General Counsel | 54 | 01/06/01 |
May Wang
PRN | Corporate Officer/Principal | 60 | 01/10/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Keung To
CHM | Chairman | 72 | 01/00/01 |
Graeme Jack
BRD | Director/Board Member | 73 | 01/17/01 |
Dan Eldar
BRD | Director/Board Member | 70 | 01/16/01 |
Edith Shih
BRD | Director/Board Member | 71 | 01/00/01 |
Paul Carter
BRD | Director/Board Member | 63 | 01/17/01 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 01/08/01 |
Wei Guo Su
CEO | Chief Executive Officer | 66 | 01/05/01 |
Ling Yang
BRD | Director/Board Member | 44 | 13/23/13 |
Shu Kam Mok
BRD | Director/Board Member | 63 | 01/17/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 871,256,270 | 456,289,920 ( 52.37 %) | 0 | 52.37 % |
Company contact information
HUTCHMED (China) Ltd.
Cheung Kong Center 2 Queen's Road Central
, Hong Kong
+852 2121 8200
http://www.hutch-med.comSector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.42% | 3.26B | |
+26.47% | 664B | |
+26.74% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.71% | 199B | |
-9.53% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- HCM Stock
- Company HUTCHMED (China) Limited